Advertisement
Advertisement
Trending on Psychiatric Times
1
Neurosterix Announces Phase 1 Study of NTX-253 for Schizophrenia
2
The Times They Are a-Changin’
3
Zervimesine May Slow Progression of Dementia With Lewy Bodies, Phase 2 Results Show
4
It’s Not Normal: A Discussion of Psychosis in Epilepsy
5